Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients
Berno, Giulia, Zaccarelli, Mauro, Gori, Caterina, Tempestilli, Massimo, Pucci, Luigia, Antinori, Andrea, Perno, Carlo Federico, Paolo Pucillo, Leopoldo, D'Arrigo, RobertaТом:
17
Мова:
english
Журнал:
Journal of the International AIDS Society
DOI:
10.7448/ias.17.4.19589
Date:
November, 2014
Файл:
PDF, 128 KB
english, 2014
File converter
Більше результатів пошуку
More benefits 
